Accelerate Diagnostics, Inc

VANGUARD GROUP INC

Report date

6/30/2023

Quarter

2023 Q2

Filed

8/14/2023

Shares

2,898,363

Value ($000)

2,348

Weight

0.0%

2013 Q4 - 2023 Q2 (18 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q2	8/14/2023	2,348	0.0%	2,898,363	6/30/2023
2023 Q1	7/14/2023	2,014	0.0%	2,876,763	3/31/2023
2022 Q4	2/10/2023	2,018	0.0%	2,859,049	12/31/2022
2022 Q3	11/14/2022	4,295	0.0%	2,825,643	9/30/2022
2022 Q2	8/12/2022	2,288	0.0%	2,304,987	6/30/2022
2022 Q1	5/13/2022	1,901	0.0%	1,320,238	3/31/2022
2021 Q4	2/14/2022	9,390	0.0%	1,798,772	12/31/2021
2021 Q3	11/12/2021	10,104	0.0%	1,732,986	9/30/2021
2021 Q2	8/13/2021	13,675	0.0%	1,696,535	6/30/2021
2021 Q1	5/14/2021	13,390	0.0%	1,609,491	3/31/2021
2020 Q4	2/12/2021	12,505	0.0%	1,649,825	12/31/2020
2020 Q3	11/16/2020	17,457	0.0%	1,637,719	9/30/2020
2020 Q2	8/14/2020	22,842	0.0%	1,506,736	6/30/2020
2020 Q1	5/15/2020	11,897	0.0%	1,428,172	3/31/2020
2019 Q4	2/14/2020	24,028	0.0%	1,421,811	12/31/2019
2014 Q2	8/11/2014	15,452	0.0%	594,272	6/30/2014
2014 Q1	5/13/2014	12,475	0.0%	572,020	3/31/2014
2013 Q4	2/12/2014	5,678	0.0%	465,369	12/31/2013